What causes acromegaly when the pituitary gland produces too much growth hormone? 

Acromegaly is a chronic and progressive medical condition characterized by the overproduction of growth hormone by the pituitary gland. This small gland sits at the base of the brain and serves as the master regulator of the endocrine system by releasing various hormones that control growth, metabolism, and reproductive health. When the gland produces an excessive amount of growth hormone, it triggers a series of physical changes and internal metabolic disruptions that affect almost every organ in the body. Because the condition develops very slowly over many years, the underlying causes often remain hidden while the body undergoes gradual transformation. In the United Kingdom, specialist endocrine teams focus on identifying the specific cellular changes within the pituitary gland to provide targeted treatments that can restore hormonal balance and prevent long term complications. 

What We’ll Discuss in This Article 

• The primary role of benign pituitary tumours in causing hormone excess. 

• How mutations in somatotroph cells lead to unregulated growth hormone release. 

• The critical interaction between growth hormone and insulin like growth factor 1. 

• Rare genetic syndromes and hereditary factors linked to acromegaly. 

• The difference between pituitary and ectopic causes of the condition. 

• How the physical size of a tumour contributes to secondary symptoms. 

• Answers to frequently asked questions about the development of the disease. 

The role of pituitary adenomas in growth hormone excess 

The vast majority of acromegaly cases are caused by a non cancerous tumour of the pituitary gland known as a pituitary adenoma. These tumours are benign, meaning they do not spread to other parts of the body, but they are highly active in secreting hormones. Specifically, these tumours arise from somatotroph cells, which are the specialized cells in the anterior pituitary responsible for producing growth hormone. When these cells multiply uncontrollably, they form a mass that pumps out growth hormone independently of the body’s actual needs. In the United Kingdom, statistics from the Society for Endocrinology indicate that acromegaly affects approximately 40 to 125 people per million, with the majority of these cases being caused by these localized pituitary growths. 

These tumours are typically classified by their size. A microadenoma is a tumour smaller than 10 millimetres, while a macroadenoma is 10 millimetres or larger. In the case of acromegaly, most patients are diagnosed with macroadenomas because the symptoms develop so slowly that the tumour has often been growing for a decade or more before it is identified. According to the NHS conditions page on acromegaly, the slow progression of these tumours is a primary reason why the average delay in diagnosis is around ten years. During this time, the tumour continues to produce growth hormone, leading to the gradual enlargement of the hands, feet, and facial features. 

Genetic mutations in somatotroph cells 

The development of a pituitary adenoma begins with a genetic change in a single somatotroph cell. This mutation is typically spontaneous, meaning it occurs by chance during a person’s life rather than being inherited from their parents. One of the most common mutations identified in clinical research involves the GNAS gene. This gene is responsible for producing a protein that acts as a switch to control the production of growth hormone. When this gene is mutated, the switch is permanently stuck in the on position, leading to the continuous and unregulated release of the hormone into the bloodstream. 

As the mutated cell clones itself, it forms the adenoma, and every new cell carries the same faulty instruction to produce excess hormone. This autonomous production is what breaks the body’s natural regulatory systems. In a healthy state, the hypothalamus would send signals to stop the pituitary from producing hormone once levels are sufficient. However, the tumour cells ignore these signals, leading to a state of chronic hormone excess. Understanding this cellular mechanism has allowed for the development of modern medications that can help to block these signals or inhibit the release of the hormone in patients who are not candidates for surgery. 

Ectopic causes of growth hormone excess 

In very rare instances, acromegaly is caused by a tumour located somewhere other than the pituitary gland. These are known as ectopic tumours and account for less than 1 percent of all cases. These tumours are typically found in the lungs, pancreas, or adrenal glands. They cause the symptoms of acromegaly in one of two ways. Some ectopic tumours produce growth hormone themselves, while others produce growth hormone releasing hormone, which then overstimulates the healthy pituitary gland to produce too much growth hormone. 

Diagnosing an ectopic cause can be a significant challenge for medical teams. If a patient has all the clinical signs of acromegaly and high IGF 1 levels but their pituitary MRI appears normal, clinicians will then look for a hidden tumour in the rest of the body using advanced imaging of the chest and abdomen. Once the ectopic tumour is located and surgically removed, the hormone levels usually return to normal. While these cases are rare, they highlight the importance of a thorough diagnostic process that considers all potential sources of hormonal disruption beyond the pituitary gland itself. 

The impact of tumour size and mass effect 

Beyond the production of hormones, the physical presence of a pituitary adenoma can cause problems due to its size and location. The pituitary gland sits in a small, bony space at the base of the brain, directly beneath the optic chiasm, where the nerves from the eyes cross. If the tumour grows large enough, it can press upwards against these nerves, leading to a loss of peripheral vision. This is a common secondary symptom that often leads to the discovery of the underlying condition. 

Tumour Size	Category	Common Clinical Symptoms
Under 10 mm	Microadenoma	Primarily hormonal symptoms like joint pain
Over 10 mm	Macroadenoma	Hormonal symptoms plus headaches and vision loss
Over 40 mm	Giant Adenoma	Significant pressure on surrounding brain tissues

The expansion of the tumour can also cause persistent, dull headaches by stretching the sensitive tissues surrounding the gland. In some cases, a very large tumour can also press on the healthy parts of the pituitary, leading to a deficiency in other essential hormones such as those that control the thyroid or adrenal glands. This complex interplay between the physical mass of the tumour and the hormonal output it generates is why acromegaly is managed as a multi system disorder by UK specialists including neurosurgeons, endocrinologists, and ophthalmologists. 

Conclusion 

Acromegaly is primarily caused by a benign pituitary tumour that produces an excessive amount of growth hormone and disrupts the body’s natural metabolic balance. While most cases arise from spontaneous cellular mutations, rare genetic syndromes and ectopic tumours can also lead to the condition. The resulting overproduction of insulin like growth factor 1 is responsible for the progressive physical changes and metabolic risks associated with the disease. Early identification through blood tests and specialized imaging is vital to prevent permanent tissue damage and protect long term health. If you experience severe, sudden, or worsening symptoms, call 999 immediately. 

Authority Snapshot (E-E-A-T Block) 

This article provides a clinical overview of the causes of acromegaly and the role of growth hormone in the body to assist in patient education. The content has been authored by a specialized medical content team and reviewed by Dr. Rebecca Fernandez to ensure the highest standards of accuracy and safety. All information presented is strictly aligned with current NHS guidelines and British endocrine society standards to provide reliable information for patients in the United Kingdom.